These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4578150)

  • 1. Partition of Salmonella typhimurium in a two-polymer acqueous phase system in relation to liability to phagocytosis.
    Stendahl O; Tagesson C; Edebo M
    Infect Immun; 1973 Jul; 8(1):36-41. PubMed ID: 4578150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of mutants of Salmonella typhimurium by counter-current distribution in an aqueous two-polymer phase system.
    Stendahl O; Magnusson KE; Tagesson C; Cunningham R; Edebo L
    Infect Immun; 1973 Apr; 7(4):573-7. PubMed ID: 4586859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacteriophage receptor development and synthesis of O-specific side chains after addition of D-galactose to the uridine diphosphate-galactose-4-epimeraseless mutant Salmonella typhimurium LT2-M1.
    Lindberg AA; Holme T; Hellerqvist CG; Svensson S
    J Bacteriol; 1970 May; 102(2):540-7. PubMed ID: 4911545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of hyperimmune immunoglobulin G on the physicochemical properties of the surface of Salmonella typhimurium 395 MS in relation to interaction with phagocytic cells.
    Stendahl O; Tagesson C; Edebo L
    Infect Immun; 1974 Aug; 10(2):316-9. PubMed ID: 4604605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Properties of a Salmonella typhimurium mutant with an incomplete deficiency of uridinediphosphogalactose-4-epimerase.
    Krishnapillai V; MacPhee DG; Stocker BA
    J Bacteriol; 1971 Jul; 107(1):155-61. PubMed ID: 4935317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemin-deficient mutants of Salmonella typhimurium.
    Săsărman A; Sanderson KE; Surdeanu M; Sonea S
    J Bacteriol; 1970 May; 102(2):531-6. PubMed ID: 4911544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiochemical consequences of opsonization of Salmonella typhimurium with hyperimmune IgG and complement.
    Stendahl O; Tagesson C; Magnusson KE; Edebo L
    Immunology; 1977 Jan; 32(1):11-8. PubMed ID: 321337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UGA nonsense mutations in Salmonella typhimurium.
    Roth JR
    J Bacteriol; 1970 May; 102(2):467-75. PubMed ID: 4315894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physicochemical surface properties and phagocytosis by polymorphonuclear leucocytes of different serogroups of Salmonella.
    Xiu JH; Magnusson KE; Stendahl O; Edebo L
    J Gen Microbiol; 1983 Oct; 129(10):3075-84. PubMed ID: 6655456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phage receptor development after the addition of galactose to a galactose-epimeraseless mutant of Salmonella typhimurium.
    Holme T; Lindberg AA
    J Gen Microbiol; 1969 Aug; 57(3):xxix. PubMed ID: 4903166
    [No Abstract]   [Full Text] [Related]  

  • 11. Galactose epimeraseless mutants of Salmonella typhimurium as live vaccines for calves.
    Clarke RC; Gyles CL
    Can J Vet Res; 1986 Apr; 50(2):165-73. PubMed ID: 3530414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of amber and ochre mutants in Salmonella typhimurium by a mutant F'-1-gal factor carrying an ochre suppressor gene.
    MacPhee DG; Stocker BA
    J Bacteriol; 1969 Oct; 100(1):240-6. PubMed ID: 4898991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of polymorphonuclear leukocytes by salmonella.
    Huixiu J; Stendahl O; Edebo L
    Acta Pathol Microbiol Immunol Scand B; 1984 Apr; 92(2):107-13. PubMed ID: 6375250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics of sensitivity of Salmonella species to colicin M and bacteriophages T5, T1, and ES18.
    Graham AC; Stocker BA
    J Bacteriol; 1977 Jun; 130(3):1214-23. PubMed ID: 324978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of phagocytosis, surface hydrophobicity and charge of Salmonella typhimurium 395 MR10 by reaction with secretory IgA (SIgA).
    Magnusson KE; Stendahl O; Stjernström I; Edebo L
    Immunology; 1979 Mar; 36(3):439-47. PubMed ID: 374252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of Salmonella typhimurium and Salmonella typhi to oxygen metabolites.
    Ishibashi Y; Arai T
    FEMS Microbiol Immunol; 1989 Apr; 1(5):279-84. PubMed ID: 2561073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on the classification of Salmonella R forms. 6. Studies on Salmonella typhimurium mutants].
    Schlecht S; Schmidt G
    Zentralbl Bakteriol Orig A; 1972 Apr; 219(4):480-93. PubMed ID: 4145483
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunity in experimental salmonellosis. II. Basis for the avirulence and protective capacity of gal E mutants of Salmonella typhimurium.
    Germanier R; Fürer E
    Infect Immun; 1971 Dec; 4(6):663-73. PubMed ID: 4949507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of Salmonella typhimurium mutants affecting the plaque morphology of phage P22.
    Rao RN; Raj CV
    Mol Gen Genet; 1971; 113(3):240-3. PubMed ID: 4946854
    [No Abstract]   [Full Text] [Related]  

  • 20. Lipopolysaccharide core mutants of Salmonella typhimurium containing D-glycero-D-manno-heptose.
    Brañes LV; Kay WW
    J Bacteriol; 1983 Jun; 154(3):1462-6. PubMed ID: 6343354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.